Richard Li

MD & CIO at Legend Capital

Mr. Li joined Legend Capital in 2001 as Vice President and was later promoted to Senior Vice President, Executive Director, and Managing Director. He is now Chief Investment Officer of the firm.

Mr. Li is responsible for LC’s investments in Amarsoft (300380.SZ), YIXINTANG (002727.SZ), La Chapelle (06116.HK), Anjie (002635.SZ), Pharmaron (300759.SZ), Lihua Group (300761.SZ), Wuxi Lead Auto Equipment (300450.SZ), Careray, Hichain, ASP, Dihon Pharmaceutical, 7gege, etc.

Mr. Li joined Legend Group in 1998, and prior to Legend Capital, he was the New Business Development Manager at the Group’s Business Development Dept.

Mr. Li holds a B.S. in Mechanical Engineering, a B.S. in Economics & Management and a master’s degree in Management Engineering from Tsinghua University, and an MBA from College Des Ingenieurs (Ecole Nationale des Ponts et Chaussées).

Timeline

  • MD & CIO

    Current role

View in org chart